Trial Profile
A Double-blind, Randomised, Placebo-controlled Multi-centre Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2017
Price :
$35
*
At a glance
- Drugs Zonisamide (Primary)
- Indications Generalised seizures; Tonic-clonic epilepsy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Eisai Inc
- 27 Mar 2012 This trial has been completed in Germany as reported by European Clinical Trials Database record (Parent trial; EudraCT2007-003557-91).
- 27 Mar 2012 This trial has been completed in Germany as reported by European Clinical Trials Database record (Parent trial; EudraCT2007-003557-91).
- 24 Mar 2012 Planned patient number is 154 as reported by European Clinical Trials Database record (Extension trial; EudraCT2007-006695-10).